Condition: Breast Cancer · Sponsor: Maisonneuve-Rosemont Hospital
Eligible women will receive neoadjuvant single fraction radiotherapy followed by surgery performed after one year
This description comes directly from the study's public registry record.
Michael Yassa · 514-252-3425 · michael.yassa.med@ssss.gouv.qc.ca
Always discuss trial participation with your own doctor first.
| Maisonneuve-Rosemont Hospital | Montreal, Quebec, Canada | Recruiting |
| McGill University Health Center | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05217966